Doctors often say labs look “normal.” Dr. Mark Hyman explains why that doesn’t always reflect wellness, and what early ...
A large-scale study has identified dozens of blood proteins linked to prostate cancer risk, some shared across populations, ...
SAN FRANCISCO (KGO) -- After last week's rain, we are in great shape for our water year so far. Most neighborhoods are above normal when it comes to rainfall levels for the first three months of the ...
SAN LUIS OBISPO, Calif. (KEYT) - Even with a rare Christmastime rainstorm set to soak the Central Coast this week, local agencies say staffing will remain at normal levels despite the storm coming ...
A prostate-specific antigen (PSA) test is a blood test that measures a protein released in the blood by prostate cells. Both normal and cancerous prostate cells release the protein. Most of the time, ...
Yakima River basin reservoirs rose sharply this week, lifting the irrigation-dependent region in Central Washington closer to recovering from last summer’s severe drought. Nearly 90,000 acre-feet of ...
The FDA has approved a novel diagnostic for prostate cancer that looks to improve upon the common screener for prostate-specific antigen, known as a PSA test. The IsoPSA blood test, developed by ...
PSA is a validated FDA-recognized clinical endpoint in assessing prostate cancer treatment response; Telomir-1 lowered PSA levels in a dose-related manner. MIAMI, FLORIDA / ACCESS Newswire / November ...
MIAMI, FLORIDA / ACCESS Newswire / November 25, 2025 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) (“Telomir” or the “Company”), a preclinical-stage biotechnology company developing therapies that ...
CLEVELAND--(BUSINESS WIRE)--Cleveland Diagnostics, Inc., a pioneering, commercial-stage precision oncology company, announced today that the U.S. Food and Drug Administration (FDA) has approved the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback